- Exchanges
- BSE, NSE
- Industry
- Pharmaceuticals
- Issue
- Book building
Amanta Healthcare IPO
₹141.75
+12.50% on listing
Listing-day close · NSE · 9 Sep 2025 · issue price ₹126
Amanta Healthcare’s ₹126 crore IPO was priced at ₹126 a share. It listed on the NSE on 9 Sep 2025 and closed its first day at ₹141.75, up 12.50% on the issue price.
Timeline
- Opens
- Closes
- Allotment
- Refunds
- Shares in demat
- Listing
Issue details
- Issue size
- ₹126 Cr
- Fresh issue
- ₹126 Cr
- Offer for sale
- —
- Lot size
- 119 shares
- Minimum investment
- ₹14,994
- Face value
- ₹10
- Registrar
- MUFG Intime India
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 57.53× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹489 Cr
- P/E (post-issue)
- 46.6
- EPS (post-issue)
- ₹2.70
- Price to book
- 3.8
- ROE
- 12.42%
- ROCE
- 13.72%
- Debt to equity
- 2.02
- EBITDA margin
- 22.11%
- PAT margin
- 3.86%
- Promoter holding
- 85.60% → 63.56%
Financials as of 31 Mar 2025, from the offer documents.
Listing
- Listing date
- 9 Sep 2025
- Issue price
- ₹126
- Open
- ₹135.00
- High
- ₹141.75
- Low
- ₹132.00
- Close
- ₹141.75
Listing day on the NSE. The close was +12.50% on the issue price.
AMANTA HEALTHCARE share price todayFAQs
When did the Amanta Healthcare IPO open and close?
It opened on 1 Sep 2025 and closed on 3 Sep 2025.
What was the Amanta Healthcare IPO price?
The price band was ₹120–126 a share. The final issue price was ₹126.
What is the lot size and minimum investment?
One lot is 119 shares, ₹14,994 at ₹126 a share. Retail investors apply in whole lots.
How much did Amanta Healthcare raise?
₹126 crore: ₹126 crore of new shares.
How many times was the Amanta Healthcare IPO subscribed?
57.53 times overall.
How did Amanta Healthcare list?
It listed on the NSE on 9 Sep 2025 at ₹135.00 and closed the day at ₹141.75, up 12.50% on the ₹126 issue price.
Who is the registrar of the Amanta Healthcare IPO?
MUFG Intime India handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app